CURRAN TERRIE received a stock award from ARCUTIS BIOTHERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/10/2026ACC: 0001628280-26-042042
Director
Since Nov 2020
+22.45K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
22.45K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+5.78K
Price / share
—
Trade value
—
% of position
32.6%
6/5/2026
17.75K→23.53K
Total
Net shares
+5.78K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/5/2026 | A · Award | +5.78K | — | — | 32.6% | 17.75K | 23.53K |
| Total | +5.78K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
16.67K shares
Shares
+16.67K
Strike price
21.23
Held after
16.67K
Exercisable
—
6/5/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock16.67K shares | 6/5/2026 | A · Award | +16.67K | 21.23 | — | 16.67K |